Daniel T. Eitzman

6.7k total citations · 1 hit paper
100 papers, 5.2k citations indexed

About

Daniel T. Eitzman is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Immunology. According to data from OpenAlex, Daniel T. Eitzman has authored 100 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 29 papers in Hematology and 20 papers in Immunology. Recurrent topics in Daniel T. Eitzman's work include Blood Coagulation and Thrombosis Mechanisms (25 papers), Protease and Inhibitor Mechanisms (17 papers) and Atherosclerosis and Cardiovascular Diseases (16 papers). Daniel T. Eitzman is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (25 papers), Protease and Inhibitor Mechanisms (17 papers) and Atherosclerosis and Cardiovascular Diseases (16 papers). Daniel T. Eitzman collaborates with scholars based in United States, China and Poland. Daniel T. Eitzman's co-authors include Randal J. Westrick, David Ginsburg, Wei Luo, Peter F. Bodary, William P. Fay, Chiao Guo, Yuechun Shen, Jason S. Knight, Miina K. Öhman and Markus Schwaiger and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Blood.

In The Last Decade

Daniel T. Eitzman

97 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.

1996 470 citations Daniel T. Eitzman, David Ginsburg et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel T. Eitzman United States	38	1.5k	1.3k	1.1k	1.0k	809	100	5.2k
Boris Bigalke Germany	37	2.9k 1.9×	767 0.6×	1.1k 1.1×	1.3k 1.3×	517 0.6×	137	6.1k
Nerea Varo Spain	37	1.9k 1.2×	938 0.7×	250 0.2×	896 0.9×	787 1.0×	85	4.3k
Coleen A. McNamara United States	42	777 0.5×	2.0k 1.6×	521 0.5×	2.2k 2.2×	787 1.0×	114	5.3k
Kinta Hatakeyama Japan	35	869 0.6×	839 0.7×	617 0.6×	903 0.9×	527 0.7×	175	3.6k
Andrew C. Newby United Kingdom	45	1.0k 0.7×	1.4k 1.1×	841 0.8×	1.9k 1.8×	544 0.7×	56	6.0k
José A. Fernández United States	42	700 0.5×	835 0.7×	3.1k 2.9×	937 0.9×	1.1k 1.3×	151	5.8k
Alberto Smith United Kingdom	40	597 0.4×	671 0.5×	593 0.6×	1.1k 1.1×	278 0.3×	96	4.2k
Yukio Ozaki Japan	39	1.9k 1.3×	835 0.7×	1.7k 1.6×	1.1k 1.1×	270 0.3×	178	6.4k
Wenche Jy United States	41	1.1k 0.7×	1.4k 1.1×	1.9k 1.7×	3.0k 2.9×	399 0.5×	121	6.1k
Makiko Ueda Japan	39	1.9k 1.2×	1.7k 1.4×	182 0.2×	1.5k 1.5×	870 1.1×	164	6.5k

Countries citing papers authored by Daniel T. Eitzman

Since Specialization

Citations

This map shows the geographic impact of Daniel T. Eitzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel T. Eitzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel T. Eitzman more than expected).

Fields of papers citing papers by Daniel T. Eitzman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel T. Eitzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel T. Eitzman. The network helps show where Daniel T. Eitzman may publish in the future.

Co-authorship network of co-authors of Daniel T. Eitzman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel T. Eitzman. A scholar is included among the top collaborators of Daniel T. Eitzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel T. Eitzman. Daniel T. Eitzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Guo, Chiao, et al.. (2024). Inhibition of sodium‐glucose cotransporter‐2 improves anaemia in mice and humans with sickle cell disease, and reduces infarct size in a murine stroke model. Journal of Cellular and Molecular Medicine. 28(17). e70091–e70091. 1 indexed citations

2.

Su, Enming J., et al.. (2023). Beta1-receptor blockade attenuates atherosclerosis progression following traumatic brain injury in apolipoprotein E deficient mice. PLoS ONE. 18(5). e0285499–e0285499. 3 indexed citations

3.

Krittanawong, Chayakrit, Rajiv Gulati, Daniel T. Eitzman, & Hani Jneid. (2021). Revascularization in Patients With Spontaneous Coronary Artery Dissection: Where Are We Now?. Journal of the American Heart Association. 10(13). e018551–e018551. 20 indexed citations

4.

Knight, Jason S., He Meng, Patrick Coit, et al.. (2017). Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target. JCI Insight. 2(18). 84 indexed citations

5.

Lauver, Adam, Hui Wang, Dandan Sun, et al.. (2016). Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis. Journal of Pharmacology and Experimental Therapeutics. 359(1). 11–17. 10 indexed citations

6.

Wang, Huili, et al.. (2013). α(1,3)-Fucosyltransferases FUT4 and FUT7 Control Murine Susceptibility to Thrombosis. American Journal Of Pathology. 182(6). 2082–2093. 7 indexed citations

7.

Eagle, Kim A., Christopher P. Cannon, William F. Armstrong, et al.. (2012). Summaries of Key Journal Articles. Journal of the American College of Cardiology. 59(14). 1255–1262. 3 indexed citations

8.

Eagle, Kim A., Christopher P. Cannon, William F. Armstrong, et al.. (2011). Summaries of Key Journal Articles. Journal of the American College of Cardiology. 59(1). 1–8. 1 indexed citations

9.

Eitzman, Daniel T., Randal J. Westrick, Yuechun Shen, et al.. (2005). Homozygosity for Factor V Leiden Leads to Enhanced Thrombosis and Atherosclerosis in Mice. Circulation. 111(14). 1822–1825. 53 indexed citations

10.

Bodary, Peter F., et al.. (2005). Recombinant Leptin Promotes Atherosclerosis and Thrombosis in Apolipoprotein E–Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 25(8). e119–22. 115 indexed citations

11.

Bodary, Peter F., Yuechun Shen, Randal J. Westrick, et al.. (2004). 1064-182 Gene transfer of an ApoA-I mimetic peptide reduces atherosclerosis in mice. Journal of the American College of Cardiology. 43(5). A465–A466. 3 indexed citations

12.

Sun, Huijun, et al.. (2003). The factor V Leiden mutation results in the in vivo loss of a critical FV anticoagulant function. Deep Blue (University of Michigan). 2 indexed citations

13.

Rajagopalan, Sanjay, Peter F. Bodary, Damon Duquaine, Bertram Pitt, & Daniel T. Eitzman. (2003). Mineralocorticoid receptor antagonism attenuates thrombotic response to injury in atherosclerosis through favorable effects on nitric oxide bioavailability. Journal of the American College of Cardiology. 41(6). 232–233. 1 indexed citations

14.

Eitzman, Daniel T., et al.. (2003). Fabry Disease in Mice Is Associated With Age-Dependent Susceptibility to Vascular Thrombosis. Journal of the American Society of Nephrology. 14(2). 298–302. 66 indexed citations

15.

He, Li, Cristina Pontes Vicente, Randal J. Westrick, Daniel T. Eitzman, & Douglas M. Tollefsen. (2002). Heparin cofactor II inhibits arterial thrombosis after endothelial injury. Journal of Clinical Investigation. 109(2). 213–219. 90 indexed citations

16.

He, Li, Cristina Pontes Vicente, Randal J. Westrick, Daniel T. Eitzman, & Douglas M. Tollefsen. (2002). Heparin cofactor II inhibits arterial thrombosis after endothelial injury. Journal of Clinical Investigation. 109(2). 213–219. 96 indexed citations

17.

Li, He, Cristina Pontes Vicente, Randal J. Westrick, Daniel T. Eitzman, & Douglas M. Tollefsen. (2002). Heparin cofactor II inhibits arterial thrombosis after endothelial injury. Journal of Clinical Investigation. 109(2). 213–219. 7 indexed citations

18.

Schmidt, Michael A., et al.. (2001). Eustachian valve endocarditis caused by Streptococcus viridans. Journal of the American Society of Echocardiography. 14(10). 1042–1043. 10 indexed citations

19.

Eitzman, Daniel T. & David Ginsburg. (1997). Of mice and men. The function of plasminogen activator inhibitors (PAIs) in vivo.. PubMed. 425. 131–41. 32 indexed citations

20.

Dahl, Juergen vom, Daniel T. Eitzman, H L Kanter, et al.. (1994). Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization.. Circulation. 90(5). 2356–2366. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact